- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: C1-esterase inhibitor - subcutaneous low dose
Total 453 results
-
CSL BehringParexelCompletedHereditary Angioedema Types I and IIUnited States, Germany
-
CSL BehringCompletedHereditary Angioedema Types I and IIUnited States, Spain, Australia, Canada, Czechia, Hungary, Israel, Italy, Romania, United Kingdom
-
AO GENERIUMWithdrawnHereditary AngioedemaRussian Federation
-
ShireCompletedHereditary AngioedemaUnited States
-
CSL BehringTerminatedAntibody-mediated RejectionUnited States, Spain, France, Netherlands, United Kingdom, Belgium, Germany
-
Novartis PharmaceuticalsCompletedTreatment-Resistant DepressionSpain, Japan, Poland, United States
-
Tampere University HospitalDeaconess Foundation; A-Clinic FoundationRecruitingSoft Tissue Injuries | Substance Dependence | Foreign Bodies | Drug Abuse, Intravenous | Needle InjuryFinland
-
CSL BehringCompletedHereditary Angioedema Types I and IIUnited States, Spain, Germany, Australia, Canada, Czechia, Hungary, Israel, Italy, Romania, United Kingdom
-
ShireCompletedHereditary AngioedemaUnited States
-
ShireCompletedGraft RejectionUnited States, Germany
-
IMMUNOe Research CentersCompletedCVI - Common Variable ImmunodeficiencyUnited States
-
CSL BehringChiltern International Inc.CompletedIncludes: Hereditary AngioedemaUnited States, Denmark, Germany, Switzerland
-
ShireCompletedHereditary AngioedemaUnited States
-
ShireCompletedHereditary Angioedema (HAE)United States
-
Stanley Jordan, MDCSL BehringCompletedKidney TransplantationUnited States
-
CSL BehringCompletedHereditary AngioedemaUnited States, Canada
-
Radboud University Medical CenterCompletedInflammation | Endotoxemia | Multi Organ Dysfunction SyndromeNetherlands
-
Haaglanden Medical CentreTakeda; Leiden University Medical CenterNot yet recruitingSubarachnoid Hemorrhage, Aneurysmal
-
Cedars-Sinai Medical CenterOneLegacy FoundationActive, not recruitingChronic Kidney Diseases | End Stage Renal DiseaseUnited States
-
ShireCompletedHereditary AngioedemaUnited States
-
ShireCompletedHereditary AngioedemaUnited States
-
ShireCompletedHereditary AngioedemaUnited States
-
Michael LevyViroPharmaCompletedNeuromyelitis OpticaUnited States
-
Johann Wolfgang Goethe University HospitalCSL Behring; University of Milan; PharmaPart; Clinical trial center Rhine-Main; ZKI... and other collaboratorsCompletedHereditary AngioedemaGermany
-
ShireCompletedHereditary Angioedema (HAE)Spain, Israel, United States, Hungary, Germany, Canada, Romania
-
Cedars-Sinai Medical CenterCompletedEnd Stage Renal Disease | Ischemic Reperfusion Injury | Kidney Failure | Delayed Graft FunctionUnited States
-
UMC UtrechtProthya BiosolutionsTerminatedSepsis | Inflammation | Trauma | Multiple Organ Dysfunction SyndromeNetherlands
-
ShireHalozyme TherapeuticsCompletedHereditary AngioedemaUnited States
-
ShireCompletedHereditary Angioedema (HAE)United States, Germany, Spain, Sweden
-
University Hospital, Basel, SwitzerlandPharming Technologies B.V.; Clinical Trial Unit, University Hospital Basel,...CompletedAcute Kidney InjurySwitzerland
-
CSL BehringCompletedHereditary AngioedemaBulgaria, United States, Poland, Spain, Hungary, United Kingdom, Russian Federation, Macedonia, The Former Yugoslav Republic of, Argentina, Australia, Canada, Czech Republic, Israel, Romania, Sweden
-
Radboud University Medical CenterUMC Utrecht; Prothya BiosolutionsCompletedSepsis | Inflammation | Endotoxemia | Innate Immune ResponseNetherlands
-
Penn State UniversityWithdrawn
-
United TherapeuticsCVie Therapeutics Co. Ltd.WithdrawnPulmonary Arterial HypertensionChina
-
Bruckner OncologyCompletedPancreatic CancerUnited States
-
Queen Mary University of LondonCompletedObesity | Endocrine; Obesity | Appetite; PervertedUnited Kingdom
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
-
Chuangzhen ChenRecruitingRadiotherapy | Immune Checkpoint Blockade | Metastatic Extracranial Malignant Solid Neoplasm | Resistance to ImmunotherapyChina
-
National Cancer Institute, EgyptRecruiting
-
ShireTerminatedAcute Antibody-Mediated Rejection (AMR)United States, Spain, France, Netherlands, Germany, Canada
-
Ministry of Health, Labour and Welfare, JapanUnknownNeoplasms | Carcinoma | Carcinoma, Hepatocellular | Liver Neoplasms | Advanced Hepatocellular CarcinomaJapan
-
Gilead SciencesNot yet recruiting
-
Mario Negri Institute for Pharmacological ResearchMinistry of Health, Italy; Azienda Ospedaliera San Gerardo di MonzaActive, not recruiting
-
University of BonnUniversity of HohenheimCompleted
-
Boehringer IngelheimCompletedPulmonary FibrosisArgentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Russian Federation, South Africa, Spain, Taiwan and more
-
ShireCompleted
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Estonia, France, Georgia, Germany, Guatemala, Italy, Latvia, Lithuania, Mexico, New Zealand, Poland, Russian Federation, South Africa, Spain, Ukraine
-
Boehringer IngelheimCompleted